CIK 0001070494
- Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061376651
- Phone
- +1 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 1,000 shares at $32.97 ($32,970)
- 4 Open-market buy Director bought 1,303,030 shares at $33.00 ($42,999,990)
- 4 Open-market sale EVP AND GC sold 16,000 shares at an average $35.00 ($560,033)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 16,637 shares (option exercise)
- 4 Open-market sale Director sold 33,697 shares at $33.53 ($1,129,999)
- 4 Option exercise Director acquired 132,839 shares (option exercise)
- 4 Open-market buy Director bought 1,449,090 shares at an average $27.08 ($39,239,808)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP AND GC sold 7,000 shares at $20.80 ($145,580)
- 4 Derivatives Options or other derivatives
Page 18 of 35 · 686 filings